Chronic glucose treatment, instead, involves prolonged or fluctuating glucose exposure lasting several days and better mimic conditions of proliferative diabetic retinopathy involving further molecular mechanisms based on more robust VEGF-A upregulation or metabolic memory processes [18]. The gene discussed is VEGFA; the disease is proliferative diabetic retinopathy.